Investors have dual reasons to be upbeat about the Moderna MRNA stock. To begin with, the FDA has finally given a nod to the COVID-19 vaccine booster shots of Pfizer PFE-BioNTech or Moderna for people with weak immune systems. The decision has come at a…
With A 32.95% Upside, Is This UK Medical Care Giant A Buy?
February 12, 2026
